Profile

ProShares Ultra Nasdaq Biotechnolog... (BIB)

$62.11

+0.03 (+0.05%)

None
NASDAQ Global Market

The fund invests in financial instruments that ProShare Advisors believes, in combination, should produce daily returns consistent with the fund's investment objective. The index is a modified capitalization weighted index that includes securities of Nasdaq listed companies that are classified as either biotechnology or pharmaceutical. The fund is non-diversified.